Latest Eckert Stories
WASHINGTON, Feb. 15, 2014 /PRNewswire-USNewswire/ -- Following is the daily "Profile America" feature from the U.S.
Plans for major new software release to be unveiled at APQC event. St. Charles, IL (PRWEB) October 03, 2013 Phil Davis, Managing Partner of St.
Reid Eckert, one of Nutritional Products International’s esteemed board members, was recently the subject of a profile article in Examiner.com. Boca Raton,
PITTSBURGH, June 30, 2011 /PRNewswire/ -- Eckert Seamans announced that the Supreme Court of the United States has granted its petition to review the decision of the United States Court of Appeals for the Ninth Circuit in Kawashima v. Holder.
BERLIN, January 21, 2011 /PRNewswire-FirstCall/ -- Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission.
BERLIN, November 23, 2010 /PRNewswire-FirstCall/ -- Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a company specializing in special compounds for the diagnosis and treatment of cancer, via its subsidiary company Eckert & Ziegler f-con Deutschland GmbH closed an exclusive sales agreement with the Karlsruhe-based ZAG Zyklotron AG for the regular delivery of Fluorodeoxyglucose (18F) (FDG).
- An imitative word; an onomatopoetic word.